Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Mid-range Performer
1067.5000 -2.20 (-0.21%)
NSE Apr 16, 2025 15:31 PM
Volume: 80,836
 

1067.50
-0.21%
Prabhudas Lilladhar
experience in manufacturing (solid/ liquid) multiple dosage offers a comprehensive range of CDMO services in India. Over time Windlas evolved and 6) strong financial performance with experienced management. It owns...
Windlas Biotech Ltd. has gained 102.01% in the last 1 Year
More from Windlas Biotech Ltd.
Recommended